TCL Archive New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor. February 24, 2006
TCL Archive NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy October 26, 1984
TCL Archive DCT Board Approves Concept Of Contract Recompetitions Worth $5.1 Million A Year July 10, 1981
TCL Archive NCI Health Disparities Center Will Attempt To Influence Policy, Harold Freeman Says November 3, 2000
